MURRAY HILL, N.J.--(BUSINESS WIRE)--Jan. 3, 2003--C. R. Bard, Inc.
(NYSE:BCR) today announced the introduction of the Ventralex(TM)
hernia patch, a simplified intra-abdominal umbilical hernia repair
technology characterized by minimal suturing, small incisions and
potentially fast recovery times.
The product was developed and is marketed by Bard's Davol, Inc.
subsidiary, located in Cranston, Rhode Island.
More than 150,000 people in the U.S. seek treatment for umbilical
hernias each year, many caused by pregnancy, childbirth, a congenital
defect or ruptured incisions from a prior surgery. The traditional
method of repairing a hernia in the "belly button" area is to use
sutures to close the tear in the abdomen; this type of repair has a
recurrence rate of 11 percent. According to a 2001 study published in
the British Journal of Medicine, however, the use of mesh in an
umbilical hernia repair reduces the rate of recurrence to 1 percent.
The Ventralex hernia patch, invented by Bard, is composed of a
round patch with a long tail or strap, which facilitates the
placement, positioning and suturing of the device in place. On one
side of the patch is a polypropylene mesh, which encourages tissue
growth into the abdominal muscle and, on the other side, an ePTFE
layer that minimizes adhesions to the prosthesis. The Ventralex hernia
patch also features a memory recoil ring that allows the patch to lie
flat in the intra-abdominal space.
Bard Chairman and Chief Executive Officer, William H. Longfield,
said, "The Ventralex hernia patch is an excellent addition to Bard's
growing ventral hernia portfolio. When added to Composix E/X Mesh,
Composix Kugel Patch and Dulex Mesh, we can now offer the general
surgeon an entire family of devices for the treatment of abdominal
hernias, further strengthening our leadership position in the area of
soft tissue repair."
C. R. Bard, Inc., (www.crbard.com), headquartered in Murray Hill,
New Jersey, is a leading multinational developer, manufacturer and
marketer of health care products in the fields of vascular, urology,
oncology and surgical specialty products.
Editors Please Note: For additional information about the
Ventralex hernia patch, surgeons may call 800-566-6756 or visit
www.davol.com for more information about Davol's surgical ventral
hernia line. Consumers may visit www.hernia.com for more general
information about hernias and hernia repair techniques.
||C. R. Bard Inc., Murray Hill
||Holly P. Glass, 703/754-2848
||Todd C. Schermerhorn, 908/277-8139